Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that a second philanthropic ...
Grocery stores can use shoppers’ personal data to charge different customers different prices, a practice known as ...
Conservative Christian advocacy organization One Million Moms (OMM) is urging its supporters to demand warnings about LGBTQ+ ...
Dawn Richard, Valerie June will perform at the Libera Awards, Universal Music expands its mental health efforts, BMG-Concord ...
Cambridge (UK) 13 May 2026 - Hybrid Software Group PLC (Euronext: HYSG) announces the result of its Annual General Meeting ...
The Round Robin Bar at Willard InterContinental Washington D.C. builds its signature mint julep with a single barrel bourbon ...
(Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of ...
The music industry's next mental health frontier is ensuring quality care, Amber Health's Dr. Chayim Newman and Zack Borer write in a new op-ed.
Search Atlas Debuts OTTO AI and White-Label SEO Platform Built for Agency Scale New York City, United States - May 7, ...
Thank you, operator, and thank you all for joining us for our first quarter 2026 earnings conference call. I will begin with ...
A federal judge has blocked the Trump administration's demands for confidential transgender patient information from Rhode ...
Invivyd Inc (IVVD) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Investments
Invivyd Inc (IVVD) reports robust monoclonal antibody revenue growth and strategic clinical investments, while navigating challenges in public education and regulatory uncertainties.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results